May 2017

Coordination of care, facilitated by a navigator, is central to the Oncology Care Model.

Patients treated with cisplatin-based chemotherapy had a higher risk of venous thromboembolism.

Recent changes to FDA labels regarding adverse events.

An ongoing phase III trial is evaluating the combination of napabucasin, a stemness inhibitor, and FOLFIRI chemotherapy in patients with metastatic colorectal cancer.

Following on dramatic advances in the understanding of tumor biology, experts have revised the classification of cancers to emphasize prognostic staging.

The Oncology Care Model (OCM) aims to reduce the cost of care and nurses can have an impact on patient outcomes while adapting to changes in practice resulting from the model.

Nearly 200 practices across the United States are piloting an ambitious new mmodel that focuses squarely on delivering high-quality, lower-cost, patient-centered care.

Effective communication can impact patient outcomes, and the patient perspective is critical in assessing these professional communicational skills.

The chances are high that hazardous drug residue exists wherever the drugs are present. What can nurses do to reduce their risks?

Some cancer treatments, as well as aging, increase the risk of patient falls. Making these basic steps a routine part of patient care can go a long way in preventing this often life-limiting complication.